WCI
검색
Login
Sign Up
Sitemap
About Us
Message from the President
Mission
History
Charter
Bylaws
Organization
Linkage with Other Organizations
Membership
Membership
Organization Members
Individual Members
Student Members
Honorary Members
ICI
ICI History
ICI Chronicles
ICI Documents
ICI Photos
Publications
Newsletters
Brochures
Annual Activity Reports
Minutes
Advisory Report
Training /Seminar
Training Courses
Materials
Communication
Announcements
Events
Q&A
RI Related News
RI Related News
Awards
Awards
Winners
Funding
Kinds of WCI funding
Acknowledgements
RI Related News
RI Related News
Home > RI Related News > RI Related News
RI Related News
LOGIN
게시글 목록
No
TItle
Name
Date
Hit
712
ITM and MTTI Sign Clinical Supply Agreement for n.c.a. Lutetium-177
WCI Secretariat
2022/05/04
3125
711
ITM Announces Successful Completion of Patient Recruitment for its Phase III Trial, COMPETE, with Lead Radiotherapeutic ITM-11 (n.c.a. lutetium-177-edotreotide)
WCI Secretariat
2022/05/04
3249
710
Facility for rare Isotope Beams to Open its Doors to Discovery
WCI Secretariat
2022/05/04
3208
709
Plus Therapeutics and Medidata Announce Expanded Clinical Trial Partnership
WCI Secretariat
2022/05/04
3112
708
Australian Prime Minister Announces Funding for Precision Medicine
WCI Secretariat
2022/05/04
3230
707
Clovis Oncology Highlights Presentations On FAP-2286 And Rubraca® (Rucaparib) At The AACR Annual Meeting 2022
WCI Secretariat
2022/05/03
3265
706
Fast Electrons Accelerate the Production of Medical Isotopes
WCI Secretariat
2022/05/03
3218
705
NorthStar Medical Radioisotopes provides Updates on Corporate progress and Progress and Upcoming Milestones
WCI Secretariat
2022/05/03
3187
704
Novartis Pluvicto™ approved by FDA as first targeted radioligand therapy for treatment of progressive, PSMA positive metastatic castration-resistant prostate cancer
WCI Secretariat
2022/04/08
3257
703
BOC Sciences Updates Product List to Expand Access to Stable Isotope-Labeled Amino Acids
WCI Secretariat
2022/04/08
3335
702
POINT Biopharma Confirms No Delays to SPLASH Trial Due to Recent Global Lutetium Supply Interruption
WCI Secretariat
2022/04/08
3231
701
Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials
WCI Secretariat
2022/04/08
3216
700
Eckert & Ziegler Extends Supply Agreement with Sirtex Medical to Chinese Market
WCI Secretariat
2022/04/08
3351
699
Telix Radiopharmaceutical Production Facility Buildout Commences
WCI Secretariat
2022/04/08
3326
698
High Flux Reactor back in full operation
WCI Secretariat
2022/04/08
3400
First
Prev
11
12
13
14
15
16
17
18
19
20
Next
End (61 Page)
Name
Title
Contents
비밀글입니다!
글작성시 입력했던 비밀번호를 입력해주세요.
비밀번호 입력